As Director of Health Technology Partnerships for Johnson & Johnson, Suzanne led complex high impact partnerships in digital health, including J&J’s enterprise relationship with Apple. She drove strategic deals for Janssen, aligning external capabilities in digital health startups and big tech with business needs across the neuroscience, cardiovascular, lung cancer treatment areas. Prior to joining J&J, at Verily Life Sciences (Alphabet), Suzanne developed user-facing aspects of clinical studies using wearable devices, working hand-in-hand with key pharma partners; she also architected customer-facing operations, including a major efficiency overhaul during a time of rapid growth. Previously, she held a senior leadership role at HealthTap, a virtual care startup, where she ran operations, sales, go-to-market, and account management. Suzanne is deeply knowledgeable in telemedicine / virtual care, clinical trial innovation, startup growth, and cross-industry partnerships in digital health.
While working full time, Suzanne earned an MBA from the Haas School of Business at the University of California, Berkeley, where she held leadership roles for her class and for the campus healthcare association.
